Searching for novel multimodal treatments in oligometastatic pancreatic cancer | BMC Cancer | Full Text

Searching for novel multimodal treatments in oligometastatic pancreatic cancer | BMC Cancer | Full Text

Searching for novel multimodal treatments in oligometastatic pancreatic cancer

Metastatic pancreatic cancer has a median overall survival of less than 12 months, even if treated with chemotherapy. Selected patients with oligometastatic disease could benefit from multimodal treatments con...

Authors:D. M. Filippini, E. Grassi, A. Palloni, R. Carloni, R. Casadei, C. Ricci, C. Serra, G. Ercolani, G. Brandi and M. Di Marco

Citation:BMC Cancer 2020 20:271

Content type:Case report

Published on: 30 March 2020

• ViewFull Text
 
• ViewPDF